142 related articles for article (PubMed ID: 15136666)
21. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
Rozsa C; Vincent A; Aranyi Z; Kovacs GG; Komoly S; Illes Z
Ideggyogy Sz; 2008 Sep; 61(9-10):325-8. PubMed ID: 18841652
[TBL] [Abstract][Full Text] [Related]
22. The immunopathogenesis of paraneoplastic neurological syndromes.
Sutton I; Winer JB
Clin Sci (Lond); 2002 May; 102(5):475-86. PubMed ID: 11980564
[TBL] [Abstract][Full Text] [Related]
23. Immunoregulatory functions for murine intraepithelial lymphocytes: gamma/delta T cell receptor-positive (TCR+) T cells abrogate oral tolerance, while alpha/beta TCR+ T cells provide B cell help.
Fujihashi K; Taguchi T; Aicher WK; McGhee JR; Bluestone JA; Eldridge JH; Kiyono H
J Exp Med; 1992 Mar; 175(3):695-707. PubMed ID: 1531495
[TBL] [Abstract][Full Text] [Related]
24. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.
Tschernatsch M; Singh P; Gross O; Gerriets T; Kneifel N; Probst C; Malas S; Kaps M; Blaes F
J Neuroimmunol; 2010 Sep; 226(1-2):177-80. PubMed ID: 20701982
[TBL] [Abstract][Full Text] [Related]
25. Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
Simister RJ; Ng K; Lang B; Beckles M; Chao D; McCabe DJ
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):344-6. PubMed ID: 20392978
[TBL] [Abstract][Full Text] [Related]
26. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.
Antunes NL; Khakoo Y; Matthay KK; Seeger RC; Stram DO; Gerstner E; Abrey LE; Dalmau J
J Pediatr Hematol Oncol; 2000; 22(4):315-20. PubMed ID: 10959901
[TBL] [Abstract][Full Text] [Related]
27. Opsoclonus-myoclonus and antineuronal antibodies in neuroblastoma.
Blatt J
Pediatr Hematol Oncol; 1996; 13(5):iii-v. PubMed ID: 10897807
[No Abstract] [Full Text] [Related]
28. Opsoclonus-myoclonus with multiple paraneoplastic syndromes and VGCC antibodies.
Josephson CB; Grant I; Benstead T
Can J Neurol Sci; 2009 Jul; 36(4):512-4. PubMed ID: 19650369
[No Abstract] [Full Text] [Related]
29. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
30. Navigating the paraneoplastic neurological syndromes.
Giannopoulou C
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):333-8. PubMed ID: 12722733
[No Abstract] [Full Text] [Related]
31. The Lambert-Eaton myasthenic syndrome.
Carpentier AF; Delattre JY
Clin Rev Allergy Immunol; 2001 Feb; 20(1):155-8. PubMed ID: 11269225
[No Abstract] [Full Text] [Related]
32. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
33. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
[TBL] [Abstract][Full Text] [Related]
34. The proliferation rate of T and B lymphocytes in cerebrospinal fluid.
Thomas RS; Beuche W; Felgenhauer K
J Neurol; 1991 Feb; 238(1):27-30. PubMed ID: 2030368
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
Corsini E; Gaviani P; Chiapparini L; Lazzaroni M; Ciusani E; Bisogno R; Silvani A; Salmaggi A; Bernardi G
J Neuroimmunol; 2016 Jan; 290():119-22. PubMed ID: 26711581
[TBL] [Abstract][Full Text] [Related]
36. Type 2 Antineuronal Nuclear Antibody in Nontumor Lambert-Eaton Myasthenic Syndrome: A Rare Association With Clinical Implications.
Zouvelou V; Daponte A; Pyrgelis ES; Boufidou F
J Clin Neuromuscul Dis; 2021 Jun; 22(4):232-233. PubMed ID: 34019010
[No Abstract] [Full Text] [Related]
37. [Paraneoplastic peripheral neuropathy due to solid cancers].
Antoine JC; Honnorat J
Rev Prat; 2008 Nov; 58(17):1890-1. PubMed ID: 19180788
[No Abstract] [Full Text] [Related]
38. Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes.
Zhang L; Qian W; Chen Q; Yin L; Li B; Wang H
Cell Immunol; 2014 Aug; 290(2):245-50. PubMed ID: 25173445
[TBL] [Abstract][Full Text] [Related]
39. B and T cell imbalances in CSF of patients with Hu-antibody associated PNS.
de Graaf M; de Beukelaar J; Bergsma J; Kraan J; van den Bent M; Klimek M; van Norden Y; Kusuma A; Smitt PS; Gratama JW
J Neuroimmunol; 2008 Mar; 195(1-2):164-70. PubMed ID: 18358542
[TBL] [Abstract][Full Text] [Related]
40. [Pathophysiology of paraneoplastic neurological syndromes: role of anti-neural antibody and antigen recognition].
Sakai K
Nihon Naika Gakkai Zasshi; 2008 Aug; 97(8):1809-15. PubMed ID: 18833692
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
